Oligopin®

DIETARY_SUPPLEMENT3 trials

Sponsors

Technological Centre of Nutrition and Health, Spain, Taipei Medical University, Les Derives Resiniques et Terpeniques

Conditions

ADHDBlood PressureHypertensionMetabolic Syndrome

Unknown Phase

Effect of Oligopin® on Blood Pressure.

CompletedNCT02063477

Technological Centre of Nutrition and Health, SpainBlood Pressure, Hypertension

Start: 2014-02-28End: 2014-10-31Updated: 2022-02-28

Therapeutic Effects of Pine Bark Extracts in Attention Deficit Hyperactivity Disorder

CompletedNCT03368690

Taipei Medical UniversityADHD

Start: 2017-10-28End: 2019-08-23Updated: 2019-09-18

A Study to Determine the Safety and Efficacy of Oligopin® on Metabolic Risk Factors in Subjects With Metabolic Syndrome

Les Derives Resiniques et TerpeniquesMetabolic Syndrome

Start: 2020-06-24End: 2022-01-10Target: 40Updated: 2021-08-26

Related Papers

Effects of low molecular weight procyanidin rich extract from french maritime pine bark on cardiovascular disease risk factors in stage-1 hypertensive subjects: Randomized, double-blind, crossover, placebo-controlled intervention trial.

2016-08-2336 citations